BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Cell Therapy
    • COVID-19
    • CAR-T
    • Cord Blood
  • Exosomes
  • Interviews
  • News
    • Press Releases
    • Job Posts
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Stem Cells » Neural Stem Cells » Page 2

Fortuna Fix Announces Series B Financing, Adding Amgen Ventures and Macnguyen Family Office as Shareholders

November 8, 2017 By Cade Hildreth (CEO)

London, UK and Montreal, Canada, November 8, 2017 (Newswire) –Fortuna Fix (“Fortuna”), a private, clinical-stage Regenerative Medicine company is aiming to be the first to bring to the clinic a patient’s own neural stem cells (autologous) produced by direct reprogramming (“drNPCs”) to replace lost neuronal tissue in neurodegeneration and neurotrauma.
[Read more…]

Filed Under: Neural Stem Cells Tagged With: Amgen, Fortuna Fix

Genetically Modified Muscle Progenitor Cells with Stem Cell Medicine Ltd.

October 2, 2017 By Cade Hildreth (CEO)

Stem Cell Medicine – A Model for Advancing Cellular Therapies in Combination with Pharmaceutical Products

In the world of stem cells, there are a number of well-recognized market participants that receive a great deal of attention from the stem cell community.

At the same time, there are brilliant companies that quietly operate under the radar screen, building themselves up one intelligent and methodical step at a time. [Read more…]

Filed Under: Interviews, MSCs, Neural Stem Cells, Stem Cells Tagged With: interview, neural stem cells, stem cell medicine

Meet the New York Scientist Using Stem Cells as a Treatment For MS

September 6, 2017 By Cade Hildreth (CEO)

treatment for ms | How Dr. Sadiq's Stem Cell Research Is Advancing Treatment of Multiple Sclerosis

Treatment for multiple sclerosis (MS) is an evolving area and one in which new therapeutic approaches are rapidly advancing. Led by Dr. Saud Sadiq, the Tisch MS Research Center of New York is pursuing a Phase II clinical trial exploring the use of stem cell technology for the treatment for MS. The announcement followed positive results from an FDA-approved Phase I stem cell trial for MS. [Read more…]

Filed Under: Interviews, MSCs, Neural Stem Cells, Stem Cells Tagged With: mMultiple sclerosis

Breakthrough Regenerative Therapeutics Company Establishes Scientific Advisory Board

May 4, 2017 By Cade Hildreth (CEO)

Montreal, Canada, May 4, 2017 – Fortuna Fix Inc., (“Fortuna”), a private, clinical-stage biotech company is aiming to be the first to eliminate the need for embryonic and fetal stem cells by using direct reprogramming of autologous cells to treat neurodegenerative diseases. Fortuna announced today the launch of its Scientific Advisory Board (“SAB”) with Professor Michael Fehlings, MD, PhD, Father Kevin FitzGerald, S.J., PhD, COL (R) Dallas Hack, MD, MPH, and Professor James Giordano, PhD. [Read more…]

Filed Under: Neural Stem Cells Tagged With: Fortuna Fix, neural stem cells, neurodegenerative disease

Stem Cell Research Products | Market Size, Segments, & Trends

February 19, 2017 By Cade Hildreth (CEO)

stem cells size | “Stem Cell Research Products – Opportunities, Tools, & Technologies” – Market Size, Segments, & Trends

“Stem Cell Research Products – Opportunities, Tools, & Technologies” is a global strategic report that evaluates opportunities across the entire stem cell product spectrum with an emphasis on opportunities for research product development.

Stem Cells Size | A Stem Cell Business Opportunity

In this article:

  • About The Global Strategic Report
  • Broad Categories Of Stem Cells
  • Stem Cell Research and Its Commercial Interest
  • Areas of Stem Cell Research
  • Big Companies in Stem Cell Research Products and Key Report Findings

[Read more…]

Filed Under: Adipose SCs, HSCs, iPS Cells, MSCs, Neural Stem Cells, Stem Cells

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 11
  • Next Page »

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn

Nanocellect

Marathon Products

Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • US Cord Blood and Cord Tissue Storage Rates Rates of U.S. Cord Blood and Cord Tissue Storage - Historical and Projected
    Rated 0 out of 5
    $197
  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • BioInformant Audience Reach BioInformant's Audience with Your Press Announcement
    Rated 0 out of 5
    $397 $297

Featured Posts

CellSource

Pediatric Stem Cell Transplantation Expert and Industry Leader Dr. Joseph Rosenthal Joins Cell Source’s Scientific Advisory Board

Feature | Exosome Companies | Exosome Companies | Tiny Exosomes, Enormous Potential

List of Exosome Companies: Tiny Packages, Enormous Potential

Dr. John Sessions

The American Academy of Stem Cell Physicians Pays Tribute to Dr. John Sessions, “Everyone’s Teacher”

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2021 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.